Skip to main content

Table 2 Clinical variables before and after administration of recombinant human DNase

From: DNase and atelectasis in non-cystic fibrosis pediatric patients

Variable

Before

After

P

Heart rate (beats/min)

150 (121–164)

130 (115–145)

0.06

Respiratory rate

41 (26–60)

36 (25–40)

0.01

PCO2 (kPa)

6.55 (5.7–8.6)

6.00 (5.3–7.5)

0.005

FiO2 (%)

50 (40–100)

40 (21–75)

<0.001

Chest X-ray score

4 (2–6)

2 (0–4)

<0.001

  1. Data presented as the median (interquartile range). Comparisons were made using the Wilcoxon signed rank test.